These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 23176198)
1. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape. Snellenberg S; De Strooper LM; Hesselink AT; Meijer CJ; Snijders PJ; Heideman DA; Steenbergen RD BMC Cancer; 2012 Nov; 12():551. PubMed ID: 23176198 [TBL] [Abstract][Full Text] [Related]
2. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098 [TBL] [Abstract][Full Text] [Related]
3. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease. Bierkens M; Hesselink AT; Meijer CJ; Heideman DA; Wisman GB; van der Zee AG; Snijders PJ; Steenbergen RD Int J Cancer; 2013 Sep; 133(6):1293-9. PubMed ID: 23456988 [TBL] [Abstract][Full Text] [Related]
4. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women. Overmeer RM; Louwers JA; Meijer CJ; van Kemenade FJ; Hesselink AT; Daalmeijer NF; Wilting SM; Heideman DA; Verheijen RH; Zaal A; van Baal WM; Berkhof J; Snijders PJ; Steenbergen RD Int J Cancer; 2011 Nov; 129(9):2218-25. PubMed ID: 21190187 [TBL] [Abstract][Full Text] [Related]
5. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes. Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975 [TBL] [Abstract][Full Text] [Related]
6. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy. Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183 [TBL] [Abstract][Full Text] [Related]
7. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Eijsink JJ; Lendvai Á; Deregowski V; Klip HG; Verpooten G; Dehaspe L; de Bock GH; Hollema H; van Criekinge W; Schuuring E; van der Zee AG; Wisman GB Int J Cancer; 2012 Apr; 130(8):1861-9. PubMed ID: 21796628 [TBL] [Abstract][Full Text] [Related]
8. Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women. De Strooper LM; Hesselink AT; Berkhof J; Meijer CJ; Snijders PJ; Steenbergen RD; Heideman DA Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1933-7. PubMed ID: 24962840 [TBL] [Abstract][Full Text] [Related]
9. Methylation Levels of CADM1, MAL, and MIR124-2 in Cervical Scrapes for Triage of HIV-Infected, High-Risk HPV-Positive Women in Kenya. De Vuyst H; Franceschi S; Plummer M; Mugo NR; Sakr SR; Meijer CJ; Heideman DA; Tenet V; Snijders PJ; Hesselink AT; Chung MH J Acquir Immune Defic Syndr; 2015 Nov; 70(3):311-8. PubMed ID: 26473640 [TBL] [Abstract][Full Text] [Related]
10. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer. De Strooper LM; van Zummeren M; Steenbergen RD; Bleeker MC; Hesselink AT; Wisman GB; Snijders PJ; Heideman DA; Meijer CJ J Clin Pathol; 2014 Dec; 67(12):1067-71. PubMed ID: 25281766 [TBL] [Abstract][Full Text] [Related]
11. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays. Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878 [TBL] [Abstract][Full Text] [Related]
12. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease. Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437 [TBL] [Abstract][Full Text] [Related]
13. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions. De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488 [TBL] [Abstract][Full Text] [Related]
14. Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women. Dankai W; Khunamornpong S; Siriaunkgul S; Soongkhaw A; Janpanao A; Utaipat U; Kitkumthorn N; Mutirangura A; Srisomboon J; Lekawanvijit S PLoS One; 2019; 14(1):e0210289. PubMed ID: 30608989 [TBL] [Abstract][Full Text] [Related]
15. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3. Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367 [TBL] [Abstract][Full Text] [Related]
16. A promising DNA methylation signature for the triage of high-risk human papillomavirus DNA-positive women. Hansel A; Steinbach D; Greinke C; Schmitz M; Eiselt J; Scheungraber C; Gajda M; Hoyer H; Runnebaum IB; Dürst M PLoS One; 2014; 9(3):e91905. PubMed ID: 24647315 [TBL] [Abstract][Full Text] [Related]
17. Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN. Uijterwaal MH; van Zummeren M; Kocken M; Luttmer R; Berkhof J; Witte BI; van Baal WM; Graziosi GCM; Verheijen RHM; Helmerhorst TJM; van Dijken DKE; Spruijt JWM; van Kemenade FJ; Fransen-Daalmeijer N; Bekker-Lettink M; Heideman DAM; Snijders PJF; Steenbergen RDM; Meijer CJLM Gynecol Oncol; 2016 Oct; 143(1):135-142. PubMed ID: 27430395 [TBL] [Abstract][Full Text] [Related]
18. Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme. de Waard J; Bhattacharya A; de Boer MT; van Hemel BM; Esajas MD; Vermeulen KM; de Bock GH; Schuuring E; Wisman GBA Clin Epigenetics; 2023 Jun; 15(1):103. PubMed ID: 37322534 [TBL] [Abstract][Full Text] [Related]
19. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study. Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort. van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]